Connect with us


South African firm tries TB vaccine on Covid-19 patients



A clinical research organization in South Africa, TASK, is testing the potency of a tuberculosis vaccine, BCG- Bacille Calmette-Guerin against Covid-19.

The vaccine, popular as an early childhood immunization has been administered on trial to 250 participants by injection and to another 250 as placebo.

A TASK spokesperson, Prof Andreas Diacon said in a statement, “South Africa does vaccinate all newborns with BCG. Re-vaccinating adults could help reduce the consequences of this pandemic,”

At least, 3,000 more participants would be administered the vaccine in Capetown and monitored for a year, the organization noted.

READ ALSO: Over 1200 inmates test positive for Covid-19 in US Prison

Meanwhile, there are 7,220 Covid-19 cases and 138 deaths so far in South Africa.

Join the conversation


Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

sixteen − 13 =